Puma Biotechnology
PBYI
PBYI
127 hedge funds and large institutions have $365M invested in Puma Biotechnology in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 45 increasing their positions, 36 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4.06% less ownership
Funds ownership: 93.2% → 89.15% (-4.1%)
35% less call options, than puts
Call options by funds: $2.22M | Put options by funds: $3.42M
Holders
127
Holding in Top 10
1
Calls
$2.22M
Puts
$3.42M
Top Buyers
| 1 | +$5.9M | |
| 2 | +$5.84M | |
| 3 | +$4.69M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$4.65M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.08M |
Top Sellers
| 1 | -$21.4M | |
| 2 | -$8.13M | |
| 3 | -$8.09M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.66M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.22M |